Inhibitors

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
Lemborexant Lemborexant 1369764-02-2 C22H20F2N4O2
Trolox Trolox 53188-07-1 C14H18O4
atpenin A5 atpenin A5 119509-24-9 C15H21Cl2NO5
Eltrombopag Eltrombopag 496775-61-2 C25H22N4O4
MIRODENAFIL MIRODENAFIL 862189-95-5 C26H37N5O5S
S-217622 S-217622 1471484-62-4 C30H33N5O5S
Bremelanotide acetate Bremelanotide acetate 1607799-13-2 C52H72N14O12
Bictegravir Bictegravir 1611493-60-7 C21H18F3N3O5
MonoMethylauristatin F MonoMethylauristatin F 745017-94-1 C39H65N5O8
Umbralisib Umbralisib 1532533-67-7 C31H24F3N5O3
DASA-58 DASA-58 1203494-49-8 C19H23N3O6S2
GUVACINE HYDROCHLORIDE GUVACINE HYDROCHLORIDE 6027-91-4 C6H10ClNO2
Dexrazoxane hydrochloride Dexrazoxane hydrochloride 149003-01-0 C11H16N4O4.ClH
2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid 2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid 594839-88-0 C14H7Cl2NO3
SB218078 SB218078 135897-06-2 C24H15N3O3
Azacosterol dihydrochloride Azacosterol dihydrochloride 1249-84-9 C25H45ClN2O
Theodrenaline Theodrenaline 13460-98-5 C17H21N5O5
Furamidine dihydrochloride Furamidine dihydrochloride 55368-40-6 C18H16N4O
hygromycin A hygromycin A 6379-56-2 C23H29NO12
CJC1295 CJC1295 863288-34-0 C152H252N44O42
4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide 4-BroMo-N-(4-broMophenyl)-3-[[(phenylMethyl)aMino]sulfonyl]benzaMide 312756-74-4 C20H16Br2N2O3S
Btk Kinase inhibitor Btk Kinase inhibitor 1351636-18-4 C25H22N6O3
Futibatinib Futibatinib 1448169-71-8 C22H22N6O3
GSK872 GSK872 1346546-69-7 C19H17N3O2S2
BMS-986205 BMS-986205 1923833-60-6 C24H24ClFN2O
PF06869206 PF06869206 2227425-05-8 C15H14ClF3N4O2
Granisetron hydrochloride Granisetron hydrochloride 1224925-76-1 C18H21D3N4O
Medetomidine Medetomidine 86347-14-0 C13H16N2
1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]- 1-Naphthalenol, 5,6,7,8-tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]- 92206-54-7 C19H25NOS
Plitidepsin Plitidepsin 137219-37-5 C57H87N7O15
LC242 LC242 187585-64-4 C37H36O14
Sparsentan (RE-021) Sparsentan (RE-021) 254740-64-2 C32H40N4O5S
Pamiparib Pamiparib 1446261-44-4 C16H15FN4O
Rupatadine Rupatadine 158876-82-5 C26H26ClN3
SD208 (TGF-Β/SMAD inhibitor) SD208 (TGF-Β/SMAD inhibitor)
APREPITANT (SUBSTANCE P antagonist) APREPITANT (SUBSTANCE P antagonist)
4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione 4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione 865854-05-3 C19H14N2O2S
PLX3397 (Pexidartinib) PLX3397 (Pexidartinib) 1029044-16-3 C20H15ClF3N5
(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid 1335316-40-9 C13H22N2O5
DM4 DM4 796073-69-3 C38H54ClN3O10S
Gadobutrol Gadobutrol 138071-82-6 C18H31N4O9.Gd
MK-677 MK-677 159634-47-6 C27H36N4O5S
2''-(5-ETHYL-3,4-DIPHENYL-PYRAZOL-1-YL)-BIPHENYL-3-YLOXY]ACETIC ACID 2''-(5-ETHYL-3,4-DIPHENYL-PYRAZOL-1-YL)-BIPHENYL-3-YLOXY]ACETIC ACID 300657-03-8 C31H26N2O3
N-(2-Hydroxyethyl)-N-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide HCl N-(2-Hydroxyethyl)-N-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide HCl 1219976-29-0 C10H17ClN4O2
Clascoterone Clascoterone 19608-29-8 C24H34O5
XL518 XL518 934660-93-2 C21H21F3IN3O2
DPO-1 DPO-1 43077-30-1 C22H29OP
Maytansinol Maytansinol 57103-68-1 C28H37ClN2O8
Alisol C 23-acetate Alisol C 23-acetate 26575-93-9 C32H48O6
Relugolix Relugolix 737789-87-6 C29H27F2N7O5S
CPI-444 CPI-444 1202402-40-1 C20H21N7O3
SR9009 SR9009 1379686-30-2 C20H24ClN3O4S
APREMILAST (PDE inhibitor) APREMILAST (PDE inhibitor)
(±)-alpha-[[(tert-butyl)amino]methyl]-7-ethyl-2-benzofuranmethanol hydrochloride (±)-alpha-[[(tert-butyl)amino]methyl]-7-ethyl-2-benzofuranmethanol hydrochloride 60398-91-6 C16H24ClNO2
2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol 2-(4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy)ethanol 128607-22-7 C24H23ClO2
NU1025 NU1025 90417-38-2 C9H8N2O2
PHA 767491 HYDROCHLORIDE PHA 767491 HYDROCHLORIDE 845714-00-3 C12H11N3O
ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE ETHYL 8-METHOXY-2-OXO-2,3,4,5-TETRAHYDRO-1H-BENZO[B]AZEPINE-4-CARBOXYLATE 869363-13-3 C25H15ClF2N4O2
CYC-116 CYC-116 693228-63-6 C18H20N6OS
VX 702 VX 702 745833-23-2 C19H12F4N4O2
BMS-754807 BMS-754807 1001350-96-4 C23H24FN9O
4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide 4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide 188591-46-0 C15H12ClF3N2O3S
PH 797804 PH 797804 586379-66-0 C22H19BrF2N2O3
PF03716556 PF03716556 928774-43-0 C22H26N4O3
PF 477736 PF 477736 952021-60-2 C22H25N7O2
CCT129202 CCT129202 942947-93-5 C23H25ClN8OS
PF-03814735 PF-03814735 942487-16-3 C23H25F3N6O2
CH5132799 CH5132799 1007207-67-1 C15H19N7O3S
Abemaciclib mesylate (LY2835219) Abemaciclib mesylate (LY2835219) 1231930-82-7 C28H36F2N8O3S
PRT062607 (Hydrochloride) PRT062607 (Hydrochloride) 1370261-97-4 C19H24ClN9O
1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide 1-Cyclopentyl-N-((4,6-diMethyl-2-oxo-1,2-dihydropyridin-3-yl)Methyl)-6-(4-(MorpholinoMethyl)phenyl)-1H-indazole-4-carboxaMide 1396772-26-1 C32H37N5O3
RN486 RN486 1242156-23-5 C35H35FN6O3
AVL-292 AVL-292 1202757-89-8 C22H22FN5O3
PD0332991 Isethionate PD0332991 Isethionate 827022-33-3 C26H35N7O6S
AZD-1208 AZD-1208 1204144-28-4 C21H21N3O2S
UNC 1999 UNC 1999 1431612-23-5 C33H43N7O2
UNC 0631 UNC 0631 1320288-19-4 C37H61N7O2
CFTRinh-172 CFTRinh-172 307510-92-5 C18H10F3NO3S2
LY310762 LY310762 192927-92-7 C24H27O2N2FHCl
IMD-0354 IMD-0354 978-62-1 C15H8ClF6NO2
BAY 11-7085 BAY 11-7085 196309-76-9 C13H15NO2S
RG108 RG108 48208-26-0 C19H14N2O4
TCS 359 TCS 359 301305-73-7 C18H20N2O4S
Ilomastat Ilomastat 142880-36-2 C20H28N4O4
2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine  hydrate  hydrochloride 2-(5-Benzo[1,3]dioxol-5-yl-2-tert-butyl-3H-imidazol-4-yl)-6-methylpyridine hydrate hydrochloride 694433-59-5 C20H21N3O2
BI-D1870 BI-D1870 501437-28-1 C19H23F2N5O2
SCH772984 SCH772984 942183-80-4 C33H33N9O2
6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine 6-(4-Methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(1E)-2-phenylethenyl]-4-pyrimidinamine 934353-76-1 C21H25N7
RO4929097 RO4929097 847925-91-1 C22H20F5N3O3
PD318088 PD318088 391210-00-7 C16H13BrF3IN2O4
LY2090314 LY2090314 603288-22-8 C28H25FN6O3
P-5091 P-5091 882257-11-6 C12H7Cl2NO3S2
CK-636 CK-636 442632-72-6 C16H16N2OS
SB 225002 SB 225002 182498-32-4 C13H10BrN3O4
SKI II SKI II 312636-16-1 C15H11ClN2OS
TTNPB (Arotinoid Acid) TTNPB (Arotinoid Acid) 71441-28-6 C24H28O2
Batimastat Batimastat 130370-60-4 C23H31N3O4S2
2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- 2-Propenamide, N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-, (2E)- 404951-53-7 C22H25N3O3
ZOTAROLIMUS ZOTAROLIMUS 221877-54-9 C52H79N5O12
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE 2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE 189224-48-4 C13H14N2O
Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.